Cigna Investments’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Sell
716
-77
-10% -$20.2K 0.03% 469
2026
Q1
$212K Sell
793
-29
-4% -$7.85K 0.03% 429
2025
Q4
$206K Hold
822
0.03% 440
2025
Q3
$236K Hold
822
0.03% 410
2025
Q2
$216K Buy
+822
New +$200K 0.04% 426
2024
Q1
Sell
-916
Closed -$208K 463
2023
Q4
$208K Buy
+916
New +$192K 0.04% 416
2023
Q3
Sell
-1,247
Closed -$258K 443
2023
Q2
$258K Hold
1,247
0.05% 377
2023
Q1
$246K Sell
1,247
-28
-2% -$5.76K 0.05% 383
2022
Q4
$258K Sell
1,275
-18
-1% -$3.52K 0.05% 368
2022
Q3
$228K Sell
1,293
-85
-6% -$17.4K 0.05% 382
2022
Q2
$278K Sell
1,378
-533
-28% -$114K 0.06% 350
2022
Q1
$434K Sell
1,911
-680
-26% -$160K 0.05% 339
2021
Q4
$700K Sell
2,591
-885
-25% -$219K 0.05% 296
2021
Q3
$840K Sell
3,476
-201
-5% -$50.7K 0.06% 288
2021
Q2
$872K Sell
3,677
-476
-11% -$108K 0.06% 284
2021
Q1
$910K Buy
4,153
+142
+4% +$28.5K 0.06% 290
2020
Q4
$702K Buy
4,011
+283
+8% +$48.9K 0.05% 313
2020
Q3
$603K Hold
3,728
0.06% 299
2020
Q2
$532K Buy
3,728
+461
+14% +$63.8K 0.05% 366
2020
Q1
$355K Buy
3,267
+174
+6% +$25.1K 0.05% 403
2019
Q4
$465K Sell
3,093
-322
-9% -$46.5K 0.05% 406
2019
Q3
$484K Buy
3,415
+174
+5% +$25.4K 0.05% 402
2019
Q2
$467K Sell
3,241
-232
-7% -$32.4K 0.05% 406
2019
Q1
$456K Hold
3,473
0.05% 408
2018
Q4
$376K Sell
3,473
-85
-2% -$11.4K 0.03% 427
2018
Q3
$490K Sell
3,558
-350
-9% -$53.2K 0.04% 366
2018
Q2
$602K Sell
3,908
-483
-11% -$72.9K 0.04% 364
2018
Q1
$610K Sell
4,391
-116
-3% -$17K 0.04% 384
2017
Q4
$619K Sell
4,507
-164
-4% -$21.7K 0.04% 386
2017
Q3
$606K Sell
4,671
-27
-0.6% -$3.6K 0.04% 382
2017
Q2
$622K Sell
4,698
-254
-5% -$31.1K 0.04% 373
2017
Q1
$610K Buy
4,952
+457
+10% +$54.1K 0.04% 384
2016
Q4
$496K Buy
+4,495
New +$499K 0.05% 403

Other funds holding LH

Cigna Investments's LH Position: Q2 2026 in Review

Cigna Investments reduced its Labcorp (LH) stake by 9.7% in Q2 2026, selling an estimated $20.2K and leaving 716 shares worth $200K. The position accounts for 0.03% of the portfolio, ranked #469.

Cigna Investments first reported a position in LH in Q4 2016 and has held it in 33 quarters since. The position peaked at $910K in Q1 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cigna Investments held 716 shares of Labcorp worth $200K as of Q2 2026.
  • Cigna Investments sold 77 Labcorp shares in Q2 2026, an estimated $20.2K.
  • Labcorp made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #469 holding.
  • Cigna Investments first reported a position in Labcorp in Q4 2016 and has held it in 33 quarters since.
  • Cigna Investments's Labcorp position peaked at $910K in Q1 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.